 SAN DIEGO, March 03, 2022 GLOBE NEWSWIRE -- Histogen Inc. NASDAQ: HSTO, a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function, today announced that Histogens financial results for the fourth quarter and year ended December 31, 2021 will be released after the close of market on Thursday, March 10, 2022. 